ARTICLE | Company News
ArQule, University of California deal
July 7, 1997 7:00 AM UTC
The parties will collaborate on the discovery and design of protease inhibitors, initially targeting Kaposi's sarcoma, herpes virus, a Chagas disease protease called cruzain, and HIV. ARQL will asses...